Cited by 337COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchAdvanced Proteomics Techniques and Applications

Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19

Open access
Shu, Ting, Ning, Wanshan, Wu, Di, Xu, Jiqian, Han, Qiangqiang, Huang, Muhan, Zou, Xiaojing, Yang, Qingyu +16 more·2020·Immunity

Abstract

The coronavirus disease 2019 (COVID-19) pandemic is a global public health crisis. However, little is known about the pathogenesis and biomarkers of COVID-19. Here, we profiled host responses to COVID-19 by performing plasma proteomics of a cohort of COVID-19 patients, including non-survivors and survivors recovered from mild or severe symptoms, and uncovered numerous COVID-19-associated alterations of plasma proteins. We developed a machine-learning-based pipeline to identify 11 proteins as biomarkers and a set of biomarker combinations, which were validated by an independent cohort and accurately distinguished and predicted COVID-19 outcomes. Some of the biomarkers were further validated by enzyme-linked immunosorbent assay (ELISA) using a larger cohort. These markedly altered proteins, including the biomarkers, mediate pathophysiological pathways, such as immune or inflammatory responses, platelet degranulation and coagulation, and metabolism, that likely contribute to the pathogenesis. Our findings provide valuable knowledge about COVID-19 biomarkers and shed light on the pathogenesis and potential therapeutic targets of COVID-19.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2020.10.008

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Severe COVID-19 is associated with elevated acute phase proteins including SAA1, SAA2, SAA4, SAP/APCS, and SERPINA3.

    “the serum amyloids A-1 (SAA1), A-2 (SAA2), and A-4 (SAA4), the serum amyloid P-component (SAP/APCS), and alpha-1-antichymotrypsin (SERPINA3) were found to be elevated in severe COVID-19”

    From COVID-19 and the human innate immune system (2021) · cites this paper as Shu et al., 2020

  • A machine-learning model using eleven plasma proteins was built to predict disease outcome.

    “a machine learning-based classifier of eleven plasma proteins, including orosomucoid-1/alpha-1-acid glycoprotein-1 (ORM1), orosomucoid-1/alpha-1-acid glycoprotein-2 (ORM2), fetuin-B (FETUB), and cholesteryl ester transfer protein (CETP), was generated to determine and predict disease outcome (Shu et al., 2020).”

    From COVID-19 and the human innate immune system (2021) · cites this paper as Shu et al., 2020

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Shu, T., Ning, W., Wu, D., Xu, J., Han, Q., Huang, M., Zou, X., Yang, Q., Yuan, Y., Bie, Y., Pan, S., Mu, J., Han, Y., Yang, X., Zhou, H., Li, R., Ren, Y., Chen, X., Yao, S., Qiu, Y., Zhang, D.-Y., Xue, Y., Shang, Y., & Zhou, X.
Affiliations
  • Chinese Academy of Sciences (CN)
  • Huazhong University of Science and Technology (CN)
  • Wuhan Union Hospital (CN)
  • Jinyintan Hospital (CN)
Corresponding author
  • Qiu, Yang
  • Zhang, Ding-Yu
  • Xue, Yu
  • Shang, You
  • Zhou, Xi
Venue
Immunity
Publisher
Elsevier BV
Published
2020-11
Volume
53
Issue
5
Pages
1108-1122.e5
ISSN
1074-7613 (ISSN-L)
OpenAlex
W3094046234
Cited by
337
References
66
Citations by year
2026: 18 · 2025: 31 · 2024: 76 · 2023: 61 · 2022: 75 · 2021: 69 · 2020: 5
FWCI
6.88
Type
journal article
Language
en
Open access
Locations
  • Immunity (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China
  • National Science and Technology Major Project
  • Chinese Academy of Sciences
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
Keywords
COVID-19 pandemic, SARS-CoV-2, plasma proteomics, biomarkers, host response, pathogenesis, machine learning, outcome prediction, immune response, inflammation, platelet secretion, coagulation, metabolic changes, therapeutic target
MeSH terms
Machine Learning, Betacoronavirus, COVID-19, SARS-CoV-2, Adult, Aged, Aged, 80 and over, Blood Proteins, Female, Humans, Male, Middle Aged, Plasma, Pneumonia, Viral, Reproducibility of Results, Biomarkers, Coronavirus Infections, Proteomics, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review